Liver Steatosis‐Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2026. Verfasst von Yu-Sheng Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antiviral Agents, Fatty Liver. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Ministry of Health and Welfare, National Science and Technology Council, Taichung Veterans General Hospital.
Abstract (Originalsprache)
Background and Aims Genetic predisposition to hepatic steatosis may increase hepatocellular carcinoma (HCC) risk after hepatitis C virus (HCV) eradication in cirrhotic patients; however, its impact on broader patient populations remains unexplored. We aimed to evaluate the association of steatosis‐polygenic risk score (PRS) with HCC following direct‐acting antiviral (DAA) therapy.
Methods
This retrospective cohort study utilised data from the Taiwan Precision Medicine Initiative, including adults treated with DAAs for HCV. Patients with treatment failure, hepatitis B virus co‐infection, significant alcohol use, or HCC diagnosis prior to sustained virological response at 24 weeks were excluded. All participants underwent genotyping, with PRS‐5 being used to quantify genetic risk. We evaluated the association between PRS‐5 and the risk of incident HCC using restricted cubic spline analysis with Cox proportional hazards models.
Results
The cohort included 420 patients (median age 67.0 years; 46.9% male). The 5‐year cumulative incidence of HCC in PRS‐5 ≥ 0.66 group was higher than PRS‐5 < 0.66 group (23.97%, 95% confidence interval (CI) 7.15%–40.79% vs. 8.89%, 95% CI 5.56%–12.23%; p = 0.014). In multivariable regression, PRS‐5 ≥ 0.66 (aSHR 3.59, 95% CI 1.69–7.63; p < 0.001), body weight index > 24 kg/m 2 (aSHR 2.68, 95% CI 1.24–5.78; p = 0.012), and Fibrosis‐4 index > 3.25 (aSHR 4.58, 95% CI 2.20–9.53; p < 0.001) were independently associated with HCC occurrence. Subgroup analysis supported the predictive value of PRS‐5 in almost all patient subgroups, including Fibrosis‐4 index < 3.25 and non‐cirrhosis.
Conclusions
PRS‐5 is independently associated with increased HCC risk after HCV eradication, supporting its role in personalised HCC surveillance strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, Chung Hsing University, Taichung, Taiwan.
- Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
- Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
- Heart Rhythm Center and Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
ORCID-Profile: Teng-Yu Lee
Förderung
- Ministry of Health and Welfare
- National Science and Technology Council
- Taichung Veterans General Hospital
Zitieren
APA
Lin, Y. S., Lin, Y. C., Chen, Y. Y., Chen, Y. M., Chen, I. C., Tsai, H. J., Chen, C. C., Lee, S. W., Yang, H. I., & Lee, T. Y. (2026). Liver Steatosis‐Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70566
Vancouver
Lin YS, Lin YC, Chen YY, Chen YM, Chen IC, Tsai HJ, et al. Liver Steatosis‐Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70566
BibTeX
@article{Lin2026,
author = {Lin, Yu-Sheng and Lin, Ying-Cheng and Chen, Yun-Yu and Chen, Yi-Ming and Chen, I-Chieh and Tsai, Hsin-Ju and Chen, Chia-Chang and Lee, Shou-Wu and Yang, Hwai-I and Lee, Teng-Yu},
title = {Liver Steatosis‐Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70566}
}
EUVIMED